Important prognostic histological parameters for patients with invasive ductal carcinoma of the pancreas (original) (raw)

Prognostic value of histological grading in ductal adenocarcinoma of the pancreas

Gino Fornaciari

International Journal of Pancreatology, 1995

View PDFchevron_right

Still a place for conventional histopathological analysis in the era of molecular medicine: predicting prognosis of resectable ductal pancreatic adenocarcinoma

Sofia de la Serna

Clinical and Translational Oncology, 2018

View PDFchevron_right

Prognostic implications of tumor diameter in carcinoma of the head of the pancreas

JOhn WIlson

Cancer, 1991

View PDFchevron_right

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma

Henry Gomez

Cancer, 2011

View PDFchevron_right

Analysis of 5-Year Survivors After a Macroscopic Curative Pancreatectomy for Invasive Ductal Adenocarcinoma

Yoshihiro Sakamoto

World Journal of Surgery, 2010

View PDFchevron_right

Ductal adenocarcinoma of the pancreas: clinicopathologic features and survival

Massimo Rugge

Tumori, 1993

View PDFchevron_right

Long-term survival after curative resection for pancreatic ductal adenocarcinoma – Surgical treatment

Gennaro Quarto

International Journal of Surgery, 2015

View PDFchevron_right

Long-term survival after curative resection for pancreatic ductal adenocarcinoma

Nuri Faruk Aykan

Journal of Clinical Oncology, 2004

View PDFchevron_right

The prognostic effect of clinical staging in pancreatic adenocarcinoma

Guido Costamagna

2005

View PDFchevron_right

Association between well-known histopathological criteria and overall survival in invasive ductal carcinoma

FİLİZ ÖZYİGİT

International journal of clinical and experimental pathology, 2015

View PDFchevron_right

Pancreatic Cancer - Clinical Course and Survival

Birgir Gudjonsson

Pancreatic Cancer - Clinical Management, 2012

View PDFchevron_right

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma

C. Partensky

Gut, 2002

View PDFchevron_right

Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry

Stig Nordling

Gut, 2005

View PDFchevron_right

Recurrence after resection for ductal adenocarcinoma of the pancreas

Cosimo Sperti

World Journal of Surgery, 1997

View PDFchevron_right

Evaluation of Prognostic Factors and Survival Results in Pancreatic Carcinomas in Turkey

Adnan Yoney

Asian Pacific Journal of Cancer Prevention, 2013

View PDFchevron_right

Survival after resection for ductal adenocarcinoma of the pancreas

Cosimo Sperti

British Journal of Surgery, 1996

View PDFchevron_right

Microscopic resection margin status in pancreatic ductal adenocarcinoma – A nationwide analysis

Ronald Van Dam

Ejso, 2021

View PDFchevron_right

Factors Influencing Survival after Resection for Ductal Adenocarcinoma of the Pancreas

Gennaro Quarto

Annals of Surgery, 1986

View PDFchevron_right

Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma means no residual tumor: no need to assess “viability”

Henry Gomez

Annals of Diagnostic Pathology, 2012

View PDFchevron_right

Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival

Sakhawat Rahman

HPB, 2013

View PDFchevron_right

Prognostic factors following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma

Hazem Zakaria

International Surgery Journal, 2018

View PDFchevron_right

Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review

Stella Nkafu

Hepatobiliary & Pancreatic Diseases International, 2014

View PDFchevron_right

Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma

Jaswinder Samra

HPB, 2016

View PDFchevron_right

The determinant factors of recurrence following resection for ductal pancreatic cancer

Roberto Salvia

JOP, 2007

View PDFchevron_right

Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma

Tsengelmaa jamiyan

World Journal of Surgical Oncology, 2020

View PDFchevron_right

Duodenal Involvement is an Independent Prognostic Factor for Patients with Surgically Resected Pancreatic Ductal Adenocarcinoma

abdulrehman Siddiqui

Annals of surgical oncology, 2017

View PDFchevron_right

Preoperative Serum CA19-9 and Dissected Peripancreatic Tissue Margin as Determiners of Long-Term Survival in Pancreatic Cancer

Keishi Yamashita

Annals of Surgical Oncology, 2009

View PDFchevron_right

Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma

Raymond Aerts

European Journal of Surgical Oncology (EJSO), 2009

View PDFchevron_right

Aggressive surgery for pancreatic duct cell cancer: Feasibility, validity, limitations

Dai Maeda

World Journal of Surgery, 1995

View PDFchevron_right

Ductal pancreatic adenocarcinoma

Waldemar Uhl

Deutsches Ärzteblatt international, 2014

View PDFchevron_right

Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma

Marius Distler, Robert Grützmann

BMC Surgery, 2013

View PDFchevron_right

Predictors of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas

Yasuhiko Tomita

JOP : Journal of the pancreas, 2014

View PDFchevron_right

Factors Affecting the Survival Trend in Carcinoma Pancreas- A Hospital Based Study

binoy paul

TAJ: Journal of Teachers Association

View PDFchevron_right

Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma

Tiina Vuorela

BMC Cancer, 2022

View PDFchevron_right

Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis

Nigel Jamieson

Clinical Cancer Research, 2011

View PDFchevron_right